IFNA1 and anemia (phenotype): Those studies are not directly comparable to our study, since RBV-containing regimens cause anemia, which impairs HRQoL.[12,43] In contrast to IFN/RBV-containing regimens,[12] the avoidance of RBV—as in this study—elucidates improvements of physical health and decreases of fatigue occurring already during therapy.